Acute Respiratory Distress Syndrome Market
Acute Respiratory Distress Syndrome Analysis Report 2024: A $2.36 Billion Market by 2032 from $1.23 Billion in 2023
July 18, 2024 06:27 ET | Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome Market Report by Type, End User, Regions and Company Analysis 2024-2032" report has been added to ...
RS BioTherapeutics Logo.jpg
RS BioTherapeutics Announces Research Collaboration with University of Colorado School of Medicine
July 08, 2024 10:00 ET | RS BioTherapeutics
CUMBERLAND, Md., July 08, 2024 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from deadly lung diseases...
ResMed logo-fullcolor.jpg
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
December 07, 2023 15:34 ET | ResMed Inc.
New study shows Chronic Obstructive Pulmonary Disease (COPD) increasing globally through 2050, with 47% growth among women.
APIE-logo.png
APIE Therapeutics Welcomes Jim Greenwood to its Board of Directors
March 21, 2023 08:00 ET | APIE Therapeutics
Cary, NC, March 21, 2023 (GLOBE NEWSWIRE) -- APIE Therapeutics (APIE Tx), a preclinical pharmaceutical company pioneering novel and proprietary drugs to activate the apelin receptor (APJ), announced...
DirectRx Pharmacy Logo
DirectRx Specialty Pharmacy Pledges Support to the COPD Foundation as a Corporate Social Responsibility Partner
March 16, 2023 12:06 ET | DirectRx Pharmacy
TROY, Mich., March 16, 2023 (GLOBE NEWSWIRE) -- DirectRx, a leading national specialty pharmacy dedicated to serving individual patients with complex and chronic health needs, today announced it has...
Logo.png
Interstitial Lung Disease Clinical Trial Pipeline Insights | DelveInsight
June 22, 2022 12:00 ET | DelveInsight Business Research LLP
Las Vegas, USA, June 22, 2022 (GLOBE NEWSWIRE) -- Interstitial Lung Disease Clinical Trial Pipeline Insights | DelveInsight Interstitial lung disease Pipeline involves 120+ key companies...
Angion_2IN-02.jpg
Angion Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary Fibrosis
May 16, 2022 00:05 ET | Angion Biomedica Corp.
-- The FDA has accepted an IND application supporting clinical development of ANG-3070 in IPF -- Phase 1b trial to be initiated to gather tolerability, safety, and pharmacokinetic data in IPF...
Phantasticals - World PH Day awareness campaign
The First PHantasticals Come to Life to Raise Awareness of Pulmonary Hypertension
May 05, 2022 05:00 ET | Ferrer
BARCELONA, Spain, May 05, 2022 (GLOBE NEWSWIRE) -- Coinciding with World Pulmonary Hypertension (PH) Day, which is celebrated every May 5, Ferrer and the European Pulmonary Hypertension Association...
TIP_link_300x300.jpg
Asthma Drugs Market Size Worth $34.13Bn, Globally, by 2028 at 5% CAGR - Exclusive Report by The Insight Partners
May 04, 2022 06:10 ET | The Insight Partners
New York, May 04, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Asthma Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Medications (Quick...
APIE-logo.png
APIE Therapeutics Augments Leadership Team with Addition of Chief Business Officer and Chief Medical Officer
January 12, 2022 07:30 ET | APIE Therapeutics
Cary, NC, Jan. 12, 2022 (GLOBE NEWSWIRE) -- APIE Therapeutics, a preclinical biopharma company pioneering microvasculature endothelium drug development by targeting the apelin receptor (APJ),...